Clinical Trial

Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer

Study acronym: IRONSTOMACH
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2019 (before its estimated November 2021 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this investigator initiated study is to study if preoperative intravenous iron is effective in reducing need for allogenic blood transfusion in patients with gastric cancer who will undergo a standardized gastrectomy including both total and subtotal gastrectomies. The hypothesis is that intravenous iron reduces the need for perioperative blood transfusions.
Trial Details
NCT Number NCT04168346
Lead Sponsor Helsinki University Central Hospital
Conditions Gastric Cancer, Anemia, Surgery, Iron Deficiency Anemia, Surgery--Complications
Enrollment 202 participants
Start Date 2019-11
Primary Completion 2021-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2019-11-19